Current status of the hormone therapy during the menopausal transition ans post-menopausa

Starting from prospectivc clinical stuclics that have evaluated its benefits and risks, hormotie replacement therapy in rnenopause wornen has been reassessecl in its indications  in the last four years. In October, 2004 a Latinarnerican Experts Consensus was carried out,  such repo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Figueroa Casas, Pedro R
Formato: Artículo revista
Lenguaje:Español
Publicado: Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2021
Materias:
.
Acceso en línea:https://revistas.unc.edu.ar/index.php/med/article/view/27899
Aporte de:
Revista de la Facultad de Ciencias Médicas de Córdoba de Universidad Nacional de Córdoba
id I10-R327-article-27899
record_format ojs
spelling I10-R327-article-278992024-08-27T18:27:49Z Current status of the hormone therapy during the menopausal transition ans post-menopausa Terapia hormonal en la transición a la menopausia y en la posmenopausia: estado actual Figueroa Casas, Pedro R . Starting from prospectivc clinical stuclics that have evaluated its benefits and risks, hormotie replacement therapy in rnenopause wornen has been reassessecl in its indications  in the last four years. In October, 2004 a Latinarnerican Experts Consensus was carried out,  such report with sorne modifications is presented in this publication. The conclusions the  experts reached were the foliowing: 1) Hormone Therapy is the goid standard for the  control of moderate to severe vasomotor symptorns; 2) this therapy mut be inclicated in an individual manner and only in syrnptomatic women in which the henefit is greater than the  risk; 3) the Ieast effective dose rnust be used; 4) it rnust he used neither for cardiovascular  prevention, osteoporosis, colon cancer nor for mental disorder; 5) the patient must be  informed about the benefits and risks.   La terapia hormonal para la mujer en menopausia ha sido revalorizada en sus indicaciones  en los últimos cuatro años, a partir de estudios clínicos prospectivos que han evaluado sus  beneficios y riesgos. En octubre de 2004 se efectuó un Consenso de Expertos  Latinoamericanos cuyo informe, con algunas modificaciones, se presenta en esta  Publicación. Las conclusiones a las que arribaron los expertos indican que: 1) la terapia hormonal es el estandar de oro para el control de los síntomas vasomotores moderados a  Severos; 2) esta terapia se debe indicar de manera individualizada y solo en mujeres  Sintomáticas en las que el beneficio sea mayor que el riesgo; 3) se debe utilizar la menor  Dosis efectiva; 4) no se debe indicar solo para prevención cardiovascular, osteoporosis,  Cáncer de colon ni para el deterioro mental; 5) se debe informar a la paciente de los  beneficios y los riesgos.   Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología 2021-03-25 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion application/pdf https://revistas.unc.edu.ar/index.php/med/article/view/27899 10.31053/1853.0605.v62.n2.27899 Revista de la Facultad de Ciencias Médicas de Córdoba.; Vol. 62 No. 2 (2005); 32 - 36 Revista de la Facultad de Ciencias Médicas de Córdoba; Vol. 62 Núm. 2 (2005); 32 - 36 Revista da Faculdade de Ciências Médicas de Córdoba; v. 62 n. 2 (2005); 32 - 36 1853-0605 0014-6722 spa https://revistas.unc.edu.ar/index.php/med/article/view/27899/29184 Derechos de autor 2021 Universidad Nacional de Córdoba https://creativecommons.org/licenses/by-nc/4.0
institution Universidad Nacional de Córdoba
institution_str I-10
repository_str R-327
container_title_str Revista de la Facultad de Ciencias Médicas de Córdoba
language Español
format Artículo revista
topic .
spellingShingle .
Figueroa Casas, Pedro R
Current status of the hormone therapy during the menopausal transition ans post-menopausa
topic_facet .
author Figueroa Casas, Pedro R
author_facet Figueroa Casas, Pedro R
author_sort Figueroa Casas, Pedro R
title Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_short Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_full Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_fullStr Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_full_unstemmed Current status of the hormone therapy during the menopausal transition ans post-menopausa
title_sort current status of the hormone therapy during the menopausal transition ans post-menopausa
description Starting from prospectivc clinical stuclics that have evaluated its benefits and risks, hormotie replacement therapy in rnenopause wornen has been reassessecl in its indications  in the last four years. In October, 2004 a Latinarnerican Experts Consensus was carried out,  such report with sorne modifications is presented in this publication. The conclusions the  experts reached were the foliowing: 1) Hormone Therapy is the goid standard for the  control of moderate to severe vasomotor symptorns; 2) this therapy mut be inclicated in an individual manner and only in syrnptomatic women in which the henefit is greater than the  risk; 3) the Ieast effective dose rnust be used; 4) it rnust he used neither for cardiovascular  prevention, osteoporosis, colon cancer nor for mental disorder; 5) the patient must be  informed about the benefits and risks.  
publisher Universidad Nacional Córdoba. Facultad de Ciencias Médicas. Secretaria de Ciencia y Tecnología
publishDate 2021
url https://revistas.unc.edu.ar/index.php/med/article/view/27899
work_keys_str_mv AT figueroacasaspedror currentstatusofthehormonetherapyduringthemenopausaltransitionanspostmenopausa
AT figueroacasaspedror terapiahormonalenlatransicionalamenopausiayenlaposmenopausiaestadoactual
first_indexed 2024-09-03T21:01:47Z
last_indexed 2024-09-03T21:01:47Z
_version_ 1809210206793498624

Ejemplares similares